QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,911 signal articles · 263 in last 24h · 109,750 total before filter · latest 46m ago
263last 24h
2448last 7d
449● bullish (7d)
223● bearish (7d)
202publishers
AllMacro246Earnings1497M&A103Regulatory17Product17Analyst23
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Why Are Intuitive Surgical (ISRG) Shares Soaring Today
StockStory14d agobullish
Why Are Intuitive Surgical (ISRG) Shares Soaring Today

Shares of medical technology company Intuitive Surgical (NASDAQ:ISRG) jumped 5.3% in the afternoon session after the company announced a collaboration with Deion “Coach Prime” Sanders to raise patient awareness of its da Vinci robotic-assisted surgery systems. The partnership aims to increase understanding of different surgical options available to patients. Sanders, a well-known sports figure, will participate in the campaign to encourage informed conversations between patients and their doctor

AMC Entertainment (AMC) Soars 10% on Record IMAX Revenue, Thanks to ‘The Odyssey’
Insider Monkey14d agobullish
AMC Entertainment (AMC) Soars 10% on Record IMAX Revenue, Thanks to ‘The Odyssey’

AMC Entertainment (NYSE:AMC) grew its share prices by 10.57 percent on Monday to end at $2.51 apiece, as investors placed bets on a combination of blockbuster box office momentum which supported strong growth prospects for the third quarter of the year. The rally followed the company’s announcement on the same day that The Odyssey delivered […]

Why Are Accenture (ACN) Shares Soaring Today
StockStory14d agobullish
Why Are Accenture (ACN) Shares Soaring Today

Shares of global professional services company Accenture (NYSE:ACN) jumped 5.9% in the afternoon session after the company announced a $2 billion share repurchase program and a new quarterly dividend, supported by strong recent earnings and positive business developments. The capital return plan acted as a catalyst for the stock, which had already seen a rebound as investors reassessed the company's position. Accenture's recent fiscal third-quarter results showed a 9% year-over-year increase in

Why Is Rivian (RIVN) Stock Soaring Today
StockStory14d agobullish
Why Is Rivian (RIVN) Stock Soaring Today

Shares of electric vehicle manufacturer Rivian (NASDAQ:RIVN) jumped 5.2% in the morning session after Piper Sandler upgraded the stock to Overweight from Neutral and raised its price target to $20 from $18.

Royal Caribbean, Carnival, Norwegian Cruise Line, American Airlines, and Delta Shares Are Soaring, What You Need To Know
StockStory14d agobullish
Royal Caribbean, Carnival, Norwegian Cruise Line, American Airlines, and Delta Shares Are Soaring, What You Need To Know

A number of stocks jumped in the morning session after a sudden de-escalation in Middle East tensions sent global oil prices tumbling. The primary macroeconomic catalyst driving today’s massive rally is a reported pause in U.S.-Iran military hostilities. With reports emerging that both Washington and Tehran are agreeing to halt attacks, fears of an escalating regional conflict are rapidly easing. This geopolitical relief valve is triggering an immediate and aggressive selloff in the energy marke

Shopify (SHOP) Jumps 11.5% on ‘High-Twenties’ Revenue Growth Hopes for Q2
Insider Monkey14d agobullish
Shopify (SHOP) Jumps 11.5% on ‘High-Twenties’ Revenue Growth Hopes for Q2

Shopify climbed by 11.54 percent on Monday to end at $126.88 apiece, as investors began positioning portfolios ahead of the results of its earnings performance in the second quarter of the year. According to the company, it is scheduled to announce its financial and operating highlights before market open on August 5. It will host […]

3 Reasons SBH is Risky and 1 Stock to Buy Instead
StockStory14d agobullish
3 Reasons SBH is Risky and 1 Stock to Buy Instead

Sally Beauty currently trades at $14.64 per share and has shown little upside over the past six months, posting a small loss of 3.7%. The stock also fell short of the S&P 500’s 6.2% gain during that period.

Rigetti (RGTI) Expands HPE Partnership To Build NSF Backed TangleLab Supercomputer
Simply Wall St.14d agobullish
Rigetti (RGTI) Expands HPE Partnership To Build NSF Backed TangleLab Supercomputer

Rigetti Computing, Hewlett Packard Enterprise and the Pittsburgh Supercomputing Center are teaming up to build TangleLab, a new hybrid quantum classical supercomputer. The system is being developed under a U.S. National Science Foundation grant and is planned as an open testbed for researchers and educators. The collaboration extends Rigetti Computing's existing work with HPE and embeds its hardware into a major academic and government backed computing project. Rigetti Computing...

AT&T (T) Expands D Wave Partnership To Rework Telecom Network Operations
Simply Wall St.14d agobullish
AT&T (T) Expands D Wave Partnership To Rework Telecom Network Operations

AT&T (NYSE:T) has expanded its quantum computing partnership with D-Wave to cover more of its telecom network operations. The agreement focuses on applying quantum tools to outage detection, technician routing, and traffic management across AT&T's network. The move shifts the collaboration from limited pilots to wider operational use within AT&T's infrastructure. AT&T operates one of the largest telecom networks in the United States, with complex infrastructure that depends on efficient...

Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial
Simply Wall St.14d agobullish
Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial

Merck (NYSE:MRK) reported that KEYTRUDA met its primary endpoint of progression free survival in the Phase 3 KEYNOTE C93 trial for advanced or recurrent endometrial cancer. The company highlighted this as the first time a PD 1 inhibitor has shown a statistically significant benefit over platinum chemotherapy in this patient population. The data are described as a high impact development for Merck's oncology portfolio, with potential implications for future regulatory filings. For investors...

Kilroy Realty (KRC) Tops Q2 FFO Estimates
Zacks14d agobullish
Kilroy Realty (KRC) Tops Q2 FFO Estimates

Kilroy Realty (KRC) delivered FFO and revenue surprises of +2.22% and -0.60%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?